BODIPY-based Probe for Amyloid-β Imaging In Vivo

Mingguang Zhu,Guoyang Zhang,Ziwei Hu,Chaofeng Zhu,Yixiang Chen,Tony D. James,Lijun Ma,Zhuo Wang
DOI: https://doi.org/10.1039/d2qo02032g
IF: 5.456
2023-03-12
Organic Chemistry Frontiers
Abstract:Alzheimer's disease (AD) is a neurodegenerative disease, and the efficient detection of amyloid-β (Aβ) plaques can greatly enhance diagnosis and therapy. Most reported probes used to detect Aβ are based on N,N-dimethylamino. As such, the design of new Aβ-recognition units facilitate the recognition of Aβ. Herein, we present a Aβ recognition unit [4-(Boc-amino) benzene] used to develop BocBD. BocBDP can recognize and image Aβ plaques both in vitro and in vivo through the interaction with amino acid residues Lys16 (K16), Val18 (V18), and Glu22 (E22). The hydrogen bonding interaction (1.9 Å) between the carbonyl oxygen atom in the Boc unit and the amino acid residue K16 allows BocBDP to bind strongly to Aβ, thus exhibiting a five-fold fluorescence enhancement and a high affinity (Kd = 67.8 ± 3.18 nM ). BocBDP can cross the BBB and image Aβ for at least 2 hours. We anticipate that our Aβ recognition unit will help improve the design of the probes that specifically recognize Aβ.
chemistry, organic
What problem does this paper attempt to address?